Mondobiotech


Mondobiotech is a Swiss-based biotechnology company focused on developing human peptides as medicaments for patients affected by rare diseases.

History

Mondobiotech was founded in 2000 by Fabio Cavalli and Dorian Bevec.[1] In March 2012, Pharma Times reported that mondoBIOTECH was “financially troubled” and was in exclusive negotiations with Pierrel Research, the contact research division of the Italian company Pierrel.[2]

Research and development

Mondobiotech creates drugs for rare diseases.

Achievements

Notes and references

See also

External links


This article is issued from Wikipedia - version of the Monday, March 09, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.